Antiarrhythmics Flashcards
Generic names
Antiarrhythmics
Adenosine
Amiodarone
Atropine
Digoxin
Disopyramide
Esmolol
Flecainide
Isoprenaline
Lidocaine (cardiovascular)
Sotalol
Verapamil
Drug class and indication
Adenosine
Antiarrhythmic
* Acute treatment of SVT
* Diagnostic aid for broad or narrow complex tachycardia
* For use with radionuclide myocardial perfusion imaging in patients unable to exercise adequately (seek specialist advice)
Tachyarrhythmias
MOA + Drug class
Adenosine
Antiarrhythmic
* Depresses sinus node activity and slows conduction through the atrioventricular node; also produces peripheral and coronary vasodilation.
* Adenosine has a rapid onset and short duration of action.
Tachyarrhythmias
Indication and drug class
Amiodarone
Antiarrhythmic
Treatment and prophylaxis of serious tachyarrhythmias refractory to other treatment, including ventricular tachycardia, AF and SVT
Tachyarrhythmias
MOA and drug class
Amiodarone
Antiarrhythmic
Decreases sinus node and junctional automaticity, slows atrioventricular (AV) and bypass tract conduction and prolongs refractory period of myocardial tissues (atria, ventricles, AV node and bypass tract); also has weak beta-blocker activity.
Tachyarrhythmias
Indication and Drug class
Digoxin
Antiarrhythmic
AF and atrial flutter
Heart failure
Heart failure, Tachyarrhythmias
MOA and drug class
Digoxin
Antiarrhythmic
Slows heart rate and reduces atrioventricular (AV) nodal conduction by an increase in vagal tone and a reduction in sympathetic activity. Increases the force of myocardial contraction by increasing the release and availability of stored intracellular calcium.
Heart failure, Tachyarrhythmias
Indication and Drug class
Disopyramide
Antiarrhythmic
Life-threatening ventricular tachyarrhythmias refractory to other treatment
Tachyarrhythmias
MOA and drug class
Disopyramide
Antiarrhythmic
Prolongs refractory period of myocardial tissue (atria, ventricles, ventricular conduction system, bypass tracts) and reduces automaticity in Purkinje fibres. It has significant anticholinergic activity, which may increase atrioventricular nodal conduction, and it also has a negative inotropic effect.
Tachyarrhythmias
Drug class and indication
Flecainide
Antiarrhythmic
* SVT
* Paroxysmal AF or atrial flutter associated with disabling symptoms
* Maintenance of sinus rhythm following cardioversion
* Serious ventricular arrhythmias refractory to other treatment (including DC cardioversion)
Tachyarrhythmia
Drug class and MOA
Flecainide
Antiarrhythmic
Slows cardiac conduction and to a lesser extent, increases refractory period in all myocardial tissues (including bypass tracts) but particularly in the His-Purkinje (ventricular conduction) system. Also has negative inotropic activity.
Tachyarrhythmia
Drug class and indication
Isoprenaline
Antiarrhythmic
* Heart block
* Bradycardia with haemodynamic compromise
* Adjunct in cardiogenic, septic or hypovolaemic shock
Bradyarrhythmia
Drug class and MOA
Isoprenaline
Antiarrhythmic
Beta agonist; increases cardiac output for bradyarrhythmia
Bradyarrhythmia
Drug class and indication
Lidocaine (cardiovascular)
Antiarrhythmic
Treatment of serious ventricular arrhythmias
Tachyarrhythmia
Drug class and MOA
Lidocaine (cardiovascular)
Antiarrhythmic
Reduces automaticity of myocardial tissue with little effect on cardiac conduction. It has a mild negative inotropic effect and weak neuromuscular blocking activity.
Tachyarrhythmia